A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection (Q34716850)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection |
scientific article |
Statements
1 reference
A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection (English)
1 reference
Fabien Zoulim
1 reference
1 January 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference